Sponsors (18)
The bill expands free PrEP access and funds community prevention efforts to reduce HIV incidence and disparities, but does so at substantial federal cost and with reimbursement, matching, and administrative requirements that could limit provider participation and program stability if funding or payment levels fall short.
Uninsured and other people at risk of HIV (including rural and other hard-to-reach populations) gain free access to FDA‑approved PrEP medications, laboratory testing, and telehealth services through a PrEP Pass, increasing direct access to prevention.
Community clinics and organizations receive federal grants and funding for outreach, peer navigation, transportation, and mental‑health supports—prioritizing high‑incidence communities and innovative delivery models—to expand local prevention capacity and reduce access disparities.
Providers are reimbursed for furnishing covered HIV prevention drugs, tests, and services, with payments aligned to existing Medicare Part B methodologies and subject to regular review, which promotes consistent payment practices and helps sustain provider participation over time.
The initiative authorizes substantial federal spending ($400M/year, FY2027–2031) and relies on congressional appropriations, creating budgetary cost and the risk that access will be inconsistent if future funding is not provided.
Reimbursement rules (providers must agree not to bill uninsured patients) and tying payments to Medicare Part B methodology risk setting rates too low or mismatched to non‑Medicare settings, which could discourage provider enrollment and reduce availability of services.
Most grant recipients must provide a 10% matching contribution, which could strain smaller community providers and rural programs and limit their ability to participate unless waivers are granted.
Based on analysis of 3 sections of legislative text.
Creates grant and reimbursement programs plus a PrEP Pass to expand no‑cost access to PrEP and related HIV prevention services for uninsured and underserved populations.
Official title: To direct the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to establish a grant program related to pre-exposure prophylaxis, and for other purposes.
Introduced February 4, 2026 by Bonnie Watson Coleman · Last progress February 4, 2026
Establishes a federal grant program and a reimbursement program to expand access to HIV pre-exposure prophylaxis (PrEP) and related prevention services. The bill funds grants to eligible entities to establish or support PrEP programs and creates a provider reimbursement system plus a “PrEP Pass” so uninsured people can receive covered services at no cost. Grants (up to $10 million each) will support clinics, testing, medications, outreach, and associated services, with a 10% grantee match (waivers allowed and Indian Tribal governments exempt). The bill authorizes $400 million per year for FY2027–2031 and requires annual reporting with disaggregated data and evaluations of impacts on PrEP disparities and prevalence.